I'm waiting for the next approval, a few weeks away.
I'll try to get us the date, so we can stay on top of it.
The FDA meeting on Sept 16 will have the next announcement of BLUEs drug approval or not.
Last week's trading restart in the middle of the day was the first I've seen in my short drug stock watching career.
We'll have to be on alert on 9/16. If the drug is approved, the stock should pop on it's next trading. But after the pop, it's been retreating.
BUT this company is likely to be bought out after it has these 2 drug approvals. So that may be where the money is.
I'm hoping to sell at the 9/16 induced pop and buy it back lower to await it's sale to a larger drug manufacturer.
Good luck to us all.